Form 8-K - Current report:
SEC Accession No. 0000917520-25-000100
Filing Date
2025-12-12
Accepted
2025-12-12 16:31:13
Documents
14
Period of Report
2025-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K iart-20251211.htm   iXBRL 8-K 28723
2 EX-10.1 exhibit101_cic2026.htm EX-10.1 109732
  Complete submission text file 0000917520-25-000100.txt   306920

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT iart-20251211.xsd EX-101.SCH 2108
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT iart-20251211_def.xml EX-101.DEF 14411
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT iart-20251211_lab.xml EX-101.LAB 25403
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT iart-20251211_pre.xml EX-101.PRE 14986
16 EXTRACTED XBRL INSTANCE DOCUMENT iart-20251211_htm.xml XML 2721
Mailing Address 1100 CAMPUS ROAD PRINCETON NJ 08540
Business Address 1100 CAMPUS ROAD PRINCETON NJ 08540 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 251568588
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)